Active Ingredient: ADENOSINE
Proprietary Name: ADENOSINE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 60MG/20ML (3MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A090450
Product Number: 001
Approval Date: Oct 2, 2014
Applicant Holder Full Name: RISING PHARMA HOLDINGS INC
Marketing Status:
Prescription
Patent and Exclusivity Information